Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeanette Seyfarth

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Molecular Immunology|August 23, 2005
Extra-hepatic transcription of the human mannose-binding lectin gene (mbl2) and the MBL-associated serine protease 1-3 genesJeanette Seyfarth, Peter Garred, Hans O Madsen
Human Molecular Genetics|August 24, 2005
The 'involution' of mannose-binding lectinJeanette Seyfarth, Peter Garred, Hans O Madsen
Medical and Pediatric Oncology|December 4, 2002
Post-induction residual disease in translocation t(12;21)-positive childhood ALLJeanette Seyfarth, Hans O Madsen, Charlotte Nyvold, et al.
Blood|February 7, 2002
Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcomeCharlotte Nyvold, Hans O Madsen, Lars P Ryder, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Molecular Immunology|August 23, 2005
Extra-hepatic transcription of the human mannose-binding lectin gene (mbl2) and the MBL-associated serine protease 1-3 genesJeanette Seyfarth, Peter Garred, Hans O Madsen
Human Molecular Genetics|August 24, 2005
The 'involution' of mannose-binding lectinJeanette Seyfarth, Peter Garred, Hans O Madsen
Medical and Pediatric Oncology|December 4, 2002
Post-induction residual disease in translocation t(12;21)-positive childhood ALLJeanette Seyfarth, Hans O Madsen, Charlotte Nyvold, et al.
Blood|February 7, 2002
Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcomeCharlotte Nyvold, Hans O Madsen, Lars P Ryder, et al.
Pageof 1